Image Credit: b-rayZ

图片提供：b-rayZ

What You Should Know:

你应该知道的：

–

–

Affidea

阿菲迪亚

, a pan-European provider of community-based polyclinics, specialist services, and advanced diagnostics, has announced a strategic collaboration with

，一家泛欧的社区综合诊所、专科服务和先进诊断服务提供商，宣布与

b-rayZ

b-rayZ

, a leader in

，领导者在

AI-powered

人工智能驱动的

breast imaging solutions.

乳腺成像解决方案。

– The strategic partnership aims to revolutionize breast cancer diagnostics by streamlining the patient pathway, enhancing precision, and improving therapeutic options for women across Europe.

这一战略合作旨在通过简化患者诊疗路径、提高精确度和改善欧洲女性的治疗选择，彻底改变乳腺癌诊断方式。

Enhancing Clinical Precision and Patient Outcomes

提升临床精确度和患者治疗效果

Affidea has chosen b-rayZ as its preferred AI partner for breast imaging, a decisive step towards making precision medicine a reality. The b-rayZ solution is already successfully in use at Affidea’s Centre of Excellence in Breast Cancer, Brust Zentrum Zurich, as well as at Affidea Givision, Site Hôpital Daler in Switzerland.

Affidea 已选择 b-rayZ 作为其乳腺成像的首选人工智能合作伙伴，这是实现精准医疗的关键一步。b-rayZ 解决方案已经在 Affidea 的卓越乳腺癌中心——苏黎世乳腺中心（Brust Zentrum Zurich）以及瑞士 Affidea Givision 的达尔医院站点成功投入使用。

Its technology has also been implemented in Affidea Lithuania and Affidea Spain, with further expansions planned in other Affidea countries offering breast imaging services. These early installations demonstrate growing confidence in b-rayZ’s ability to standardize and elevate diagnostic quality across diverse clinical environments..

该技术也已在立陶宛Affidea和西班牙Affidea实施，并计划在其他提供乳腺成像服务的Affidea国家进一步推广。这些早期的安装展示了人们对于b-rayZ能够在各种临床环境中标准化并提升诊断质量的能力越来越有信心。

The collaboration addresses the current fragmentation in breast cancer diagnostics, where critical information often scattered across different modalities and specialists can slow down decision-making and delay life-saving treatments . b-rayZ’s AI-powered platform is designed to eliminate these gaps, ensuring a seamless diagnostic pathway..

该合作旨在解决当前乳腺癌诊断领域的碎片化问题，关键信息常常分散在不同的检测方式和专科医生之间，这可能会减慢决策速度并延误挽救生命的治疗。b-rayZ 的人工智能平台旨在消除这些差距，确保无缝的诊断路径。

“Breast imaging is a highly specialised field that requires precision, experience, and the ability to interpret complex data. AI-powered solutions, like those developed by b-rayZ, are revolutionising breast cancer diagnostics by augmenting radiologists’ expertise and ensuring greater consistency in detection.

“乳腺成像是一个高度专业化的领域，需要精确性、经验以及解读复杂数据的能力。像b-rayZ开发的那些由人工智能驱动的解决方案，通过增强放射科医生的专业知识并确保检测中更大的一致性，正在彻底改变乳腺癌诊断。

Through this partnership, we are integrating AI to enhance our sub-specialty breast imaging, improving diagnostic accuracy, and optimising personalised screening pathways. This marks a significant step forward in delivering earlier diagnoses, reducing variability in interpretations, and ultimately ensuring the best possible clinical outcomes for women across Europe,” said Dr.

通过这一合作，我们正在整合人工智能以增强我们的乳腺亚专科影像技术，提高诊断准确性，并优化个性化的筛查路径。这标志着我们在提供更早期的诊断、减少解读变异性，并最终确保欧洲女性获得最佳临床结果方面迈出了重要的一步。”

Alessandro Roncacci, SVP and chief medical officer at Affidea..

亚历山德罗·隆卡奇，Affidea高级副总裁兼首席医疗官。